MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/0002-9378(93)90048-n

Медицинская библиотека · American journal of obstetrics and gynecology · 1993

Effects of hydralazine on pregnant rats and their fetuses.

Pryde P G, Abel E L, Hannigan J, Evans M I, Cotton D B

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

We conducted this study to assess potential teratogenic or fetotoxic effects of in utero hydralazine exposure in the rat.

STUDY

DESIGN

Pregnant rats were treated with hydralazine (0, 15, or 30 mg/kg/day) by either gavage or subcutaneous injection during gestation days 8 through 19, inclusively. Surviving animals were killed, uterine contents examined, and fetuses evaluated by Wilson's method for teratologic examination.

RESULTS

Oral administration did not affect maternal weight gain or fetal or placental weights. Subcutaneous administration decreased fetal and placental weights but only in dams given the highest dose subcutaneously; significantly increased maternal mortality and reduced maternal weight gain were also observed. There was no increased incidence of fetal anomalies in any group.

CONCLUSION

Hydralazine does not have teratogenic or fetopathic effects when given to rats in dosages that are nontoxic to the mother.

Для цитирования: Pryde P G, Abel E L, Hannigan J, Evans M I, Cotton D B. Effects of hydralazine on pregnant rats and their fetuses.. American journal of obstetrics and gynecology. 1993. DOI: 10.1016/0002-9378(93)90048-n.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.